LATEST PSYCHEDELICS STOCKS NEWS

Champignon Announces Closing of $15 Million Bought Deal Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, June 11, 2020 -- Champignon Brands Inc. (โ€œChampignonโ€ or the โ€œCompanyโ€) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, is please... Read More...

IntelGenx Provides Update on RIZAPORTยฎ VersaFilmยฎ NDA Resubmission Process Following Type A Meeting with the FDA

SAINT LAURENT, Quebec, June 11, 2020 -- Saint Laurent, Quebec, June 11, 2020 โ€“ IntelGenx Corp. (TSX V:IGX)(IGXT) (the "Company" or "IntelGenx") today provided an update regarding its RIZAPORTยฎ VersaFilmยฎ program following its Type A meeting with the U.S. Food & Drug Administration ("FDA") that took place on June 10, 2020.On March 27, ... Read More...

Numinus receives Health Canada licence amendment to produce and extract psilocybin from mushrooms

Numinus becomes first publicly traded company in Canada approved to conduct research of this kind under a Health Canada licence VANCOUVER, BC, June 11, 2020 - Numinus Wellness Inc. (TSX-V:NUMI) ("Numinus") has received Health Canada approval to amend the Company's existing Licence under the Controlled Drug and Substances Act to allow Numi... Read More...

Hollister Bioscience’s 100% Owned Subsidiary Venom Extracts Generates Record Monthly Revenue in May 2020

VANCOUVER, BC , June 11, 2020 -ย Hollister Biosciences Inc. (HOLL.CN) (HSTRF)ย (HOB.F) (the "Company", "Hollister Cannabis Co." or " Hollister ") a diversified cannabis branding company with products in over 220 dispensaries throughout California , is pleased to announce that its 100% owned subsidiary Venom Extracts ("Venom") generated reco... Read More...

Nutritional High Cancels Debenture Conversion and Rollback and Announced Settlement of Payables

Toronto, Ontario--(Newsfile Corp. - June 10, 2020) - Nutritional High International Inc. (CSE: EAT) (OTCQB: SPLIF) ("Nutritional High" or the "Company") announces that it will cancel its meeting of the 10% Senior Unsecured Convertible Debentures due March 14, 2021 scheduled for July 8, 2020.Due to recent corporate developments including t... Read More...

EGF Theramed Health Amends Financing

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICESVANCOUVER, BC / ACCESSWIRE / June 10, 2020 / EGF THERAMED HEALTH CORP. (TMED.CN)(EVAHF)(AUHP.F) (the "Company") reports that further to the Company's press release dated May 22, 2020, the Company has amended the terms of the financing to raise up to C... Read More...

Codebase Ventures Inc. Updates Its World High Life Investment as Love Hemp Appoints Chief Scientific & Regulatory Advisor

VANCOUVER, BC / ACCESSWIRE / June 10, 2020 / Codebase Ventures Inc. ("Codebase") (CODE.CN)(C5B.F)(BKLLF) an investment company, is providing an update on its investment in World High Life Plc (LIFE) (WRHLF).World High Life's wholly owned subsidiary, Love Hemp Ltd (Love Hemp), has announced that it has appointed Dr. Sepe Sehati as Chief Sc... Read More...

PSYC Expanding Their Global Reach To Showcase Psychedelic Industry Leaders and Pioneers

SAN DIEGO, CA, June 10, 2020 -- Global Trac Solutions, Inc. (OTCPink: PSYC) (โ€œGlobalโ€ โ€œPSYCโ€ or the โ€œCompanyโ€) is pleased to announce that in an effort to provide its growing base of Psychedelic Spotlight newsletter subscribers with exclusive content surrounding the ongoing boom within the medicinal psychedelics space, the Company plans t... Read More...

IntelGenx Poised to Launch Hand Sanitizer Business Following Receipt of Health Canada Authorization for Commercial Sale

First Purchase Order Received, with Product Availability Expected by early Q3-2020SAINT LAURENT, Quebec, June 10, 2020 -- IntelGenx Corp. (TSX V:IGX)(IGXT) (the "Company" or "IntelGenx") today announced that Health Canada has authorized the sale of IntelGenxโ€™s hand sanitizer product, both in liquid and gel formulations, which will be manu... Read More...

Empower Launches Covid-19 Testing in Oregon and Provides Support on The Oregon IP34 Psilocybin Initiative

Empower has commenced phase one and phase two COVID-19 testing in Oregon for existing and new patients, and supports Oregon ballot IP34 by collecting signatures in its Portland wellness clinic to advance Oregon's psilocybin therapy initiativeVANCOUVER, BC / ACCESSWIRE / June 10th, 2020 / EMPOWER CLINICS INC. (CBDT.CN) (EPWCF) (8EC.F) ("Em... Read More...

Mota Ventures Reports Monthly Revenues of Cdn$5,141,000 for Natures Exclusive, Highest in the History of the Brand, Representing, an Increase of 110% from May 2019

VANCOUVER, BC, CANADA / ACCESSWIRE / June 10, 2020 / Mota Ventures Corp. (MOTA.CN) (1WZ1.F)(OTC PINK:PEMTF) (the "Company") the Company's subsidiary, Nature's Exclusive, an eCommerce provider of CBD products to consumers in the United States, is pleased to announce an all-time monthly revenue record achieved during May 2020. Revenue for t... Read More...

Core One Labs Requests Management Cease Trade Order for Additional Time to Complete Annual Financial Statements and Related Filings

Vancouver, British Columbia--(Newsfile Corp. - June 9, 2020) - ย Core One Labs Inc. (CSE: COOL) (OTCQX: CLABF) (FSE: LD6) (WKN: A14XHT) ("COOL" or the "Company") announced today that it anticipates additional delays in filing its financial statements for the year ended December 31, 2019 and the related management's discussion and analysis ... Read More...

Revive Therapeutics Provides Update on Discussions with Health Canadaย in Pre-CTA Meeting

TORONTO, June 09, 2020 -- Revive Therapeutics Ltd. (โ€œReviveโ€ or the โ€œCompanyโ€) (CSE:RVV), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that the Company met with Health Canada in a Pre-Clinical Trial Application (โ€œPre-CTAโ€) meeting to ... Read More...

Phase 2 Clinical Trial of LSD for “Suicide Headaches” Begins Treating Patients

MindMed Is Collaborating on a Phase 2 Clinical Trial of LSD For Cluster Headaches with University Hospital Basel's Liechti LabBASEL, Switzerland , June 8, 2020 --ย Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF), is supporting and collaborating on a Phase 2 clinical trial evaluating LSD for the treatment of cluster headaches at Unive... Read More...

Champignon Identifies Synthetic Ketamine and Psilocybin/Psilicin Metabolite Targets; Selects Dalriada to Advance NCE IP Portfolio

VANCOUVER, British Columbia, June 08, 2020 -- Champignon Brands Inc. (โ€œChampignonโ€ or the โ€œCompanyโ€) (SHRM.CN) (496.F) (SHRMF), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, is pleased to announce it has selected Toronto-based Dalriada Drug Discovery Inc. (โ€œDalriadaโ€) to advance its new chemi... Read More...

Mota Ventures Signs Binding Term Sheet to Acquire E-Commerce Platform Leader Unified Funding with C$93.8 Million in Consumer Transactions Facilitated In

VANCOUVER, BC / ACCESSWIRE / June 6, 2020 / Mota Ventures Corp. (MOTA.CN)(FSE:1WZ:GR)(OTC PINK:PEMTF) (the "Company") is pleased to announce that it has entered into a binding term sheet (the "Term Sheet") dated June 5, 2020 with Unified Funding LLC ("Unified"). The term sheet replaces the previous preliminary letter of intent entered int... Read More...

UPDATE: Ehave, Inc. To Acquire MDLink The Largest Telemedicine Platform in The CARICOM Countries And To Launch MDLink Mental Therapy along with Psychedelic Treatments To Address Mental Health

MIAMI, June 05, 2020 -- Ehave, Inc., (OTC Pink: EHVVF) (the โ€œCompanyโ€), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, today announced it has signed a letter of intent to acquire 51% of MDLink a Caribbean Telemedicine provider, MDLink Limited ("MDLink"), a company organized and existing... Read More...

Core One Labs Announces Private Placement Financing and Non-Binding Letter of Intent to Acquire Medical Clinics

Vancouver, British Columbia--(Newsfile Corp. - June 5, 2020) - Core One Labs Inc. (CSE: COOL) (OTCQX: CLABF) (FSE: LD61) (WKN: A14XHT) (the "Company") is pleased to announce that it has entered into a non-binding letter of intent (the "Letter of Intent"), dated June 4, 2020, with Rejuva Alternative Medicine Research Centre Inc. ("Rejuva")... Read More...

Primo Nutraceuticals Inc., and World Agri Minerals Ltd. Discuss Potential Development of a Proprietary Natural Mineral Blend to Increase Production for Mushroom Growers

VANCOUVER, British Columbia, June 05, 2020 -- PRIMO NUTRACEUTICALS INC. (CSE:PRMO) (BUGVF) (8BV.F) (8BV.F) (8BV.MU) (8BV.SG) ("Primo") is pleased to announce that further to its letter of intent (โ€œLOIโ€) with World Agri-Minerals Ltd. (โ€œWAMโ€), announced in the Companyโ€™s news release dated June 4, 2020, Primo and WAM have conducted discussio... Read More...

Osoyoos Provides Update on Annual and Special Meeting

Toronto, Ontario--(Newsfile Corp. - June 4, 2020) - Osoyoos Cannabis Inc. (CSE: OSO) ("Osoyoos" or the "Company") announced today that the Company has rescheduled its next annual and special meeting of shareholders (the "Annual Meeting") to be held on August 7, 2020.Management had initially scheduled its Annual Meeting to be held on July ... Read More...

Nutritional High Pleased to Announce the Formation of Psychedelic Science Corp and Appointment of New Management, by Kruzo LLC

Toronto, Ontario--(Newsfile Corp. - June 4, 2020) - Nutritional High International Inc. (CSE: EAT) (OTCQB: SPLIF) (FSE: 2NU) ("Nutritional High" or the "Company") is pleased to announce that Kruzo LLC ("Kruzo") has formed Psychedelic Science Corp to facilitate its previously announced acquisition by the Company on June 1, 2020. Psychedeli... Read More...

MindMed Launches Project Lucy Focused on LSD Experiential Therapy For Anxiety Disorders

Targeting a Phase 2b psychedelic assisted therapy trial for the treatment of anxiety disordersNEW YORK, June 4, 2020 -- Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF), the leading neuro-pharmaceutical company for psychedelic inspired medicines, has officially launched Project Lucy, a commercial drug development program for the trea... Read More...

Hollister Biosciences Inc. Subsidiary AlphaMind Brands Inc. Plans to Launch Initial Medicinal Mushroom Based Product Line

VANCOUVER, BC , June 4, 2020 - Hollister Biosciences Inc. (HOLL.CN) (HSTRF) (HOB.F) (the "Company", "Hollister Cannabis Co." or " Hollister ") a diversified cannabis branding company with products in over 220 dispensaries throughout California , is pleased to announce that the Company's 100% owned subsidiary, AlphaMind Brands Inc. ("Alpha... Read More...

Revive Therapeutics Announces Filing of a Pre-CTA Meeting Request with Health Canada and Update on U.S. FDA IND Filing and Phase 3 Clinical Trial Design for Bucillamine in the Treatment of COVID-19

TORONTO, June 03, 2020 -- Revive Therapeutics Ltd. (โ€œReviveโ€ or the โ€œCompanyโ€) (CSE:RVV), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has filed its Clinical Trial Application (โ€œPre-CTAโ€) with Health Canada and provides an upd... Read More...

Primo Nutraceuticals Inc. Signs Letter of Intent to Enter into Funding and Asset Purchase Agreement with World Agri Minerals Ltd.

VANCOUVER, British Columbia, June 03, 2020 -- PRIMO NUTRACEUTICALS INC. (CSE:PRMO) (BUGVF) (8BV.F) (8BV.F) (8BV.MU) (8BV.SG) ("Primo") is pleased to announce that it has signed a non-binding letter of intent (โ€œLOIโ€) to provide funding and to acquire up to 100% of the assets and inventory of World Agri Minerals Ltd. (โ€œWAMโ€), together (the ... Read More...

PSYC Attracts Hundreds of Subscribers For Their Monthly Newsletter Launch in June

SAN DIEGO, June 03, 2020 -- Global Trac Solutions, Inc. (PSYC) (โ€œGlobalโ€ โ€œPSYCโ€ or the โ€œCompanyโ€) is pleased to announce that as part of the successful launch of its Psychedelic Spotlight website (www.psychedelicspotlight.com) last week, the Company has added hundreds of new email subscribers for the monthly newsletter, which will cover t... Read More...

MDLinkย to Launch Coronavirus Screening Tool and Intends to Provide Rapid Test Kits to Tourist

MDLink's Artificial Intelligence Novel Coronavirus Screening Online Platform Will be Free to the PublicMIAMI, Fla., June 03, 2020 -- Ehave, Inc., (OTC Pink: EHVVF) (the โ€œCompanyโ€), a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced on Tuesday, June 2, 2020 it had signed a letter o... Read More...

Core One Labs to Establish a Shareholder Advisory Board

Vancouver, British Columbia--(Newsfile Corp. - June 3, 2020) - Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (FSE: LD6) (WKN: A14XHT) ("COOL") is pleased to announce that it will establish a Shareholder Advisory Board (the "Advisory Board"). The advisory board will consist of three current shareholders who have had interest and involvem... Read More...